And there we have it. No adverse effects.
Looking forward to 2017 news flow.
Ann: Prima announces TACTI-mel clinical trial data, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 31.0¢ | 29.0¢ | $504.5K | 1.673M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39998 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 3997 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |